Table 2. Consequences of falsely labeling of patients as β-lactam allergic for the antimicrobial stewardship program.
| – Prescription of less suitable antibiotics (“second choice”) |
| – Delay in antibiotic therapy |
| – Higher healthcare costs |
| – Greater prevalence of antibiotic resistant germs |
| – More frequent treatment failures |
| – Longer hospital stays |
| – Higher mortality risk |
| – More frequent treatment in intensive care |